Stellar Results Tinged by Disappointment

There was great anticipation ahead of today's results for both AMYT:Amryt Pharma and IQE:IQE.

The results were both fantastic. Amryt reporting the granting of a US patent for Episalvan as well as an encouraging half year report, and IQE delivering a blistering interim statement with pre-tax profit up by 71%.

I buckled up for the ride.

I needn't have bothered, as it turned out to be a merry-go-round.

AMYT:Amryt Pharma shot up from 20.25p to 22.5p at first. That sort of increase would have been worth a £600 rise in potential profit, but it soon drifted back down to end up just 0.25p up at 20.5p. At least the bid price rose by 0.5p so I finished up by £136.

IQE:IQE also climbed to begin with, from 28.25p to 30.5p. Not massive but at least it suggested I hadn't bought on a spike again. This one drifted right down to 27.5p before staging a recovery to 28p. That's lower than my purchase price yesterday so this is now losing £27. Not quite what I was hoping for after such good results, but clearly the results were expected and priced in. I missed the opportunity to buy in June/July at 18p. If only I had got to the letter I quicker in my research! I don't care, as I think these could easily double in value over the next year or two, and there's likely to be loads of exciting news along the way.

Today was the opposite to yesterday when I thought I was in for a loss but got a big gain. Today I expected a big gain and got a tiny one, although I'm confident the reason will be short lived, and the headline is that the combined portfolios are now within £200 of being in paper profit!

The combined share account and ISAs are only down by £1,506 (compared to £6,500 post Brexit) and the SIPP is up by £1,297. Even the trading account is looking good after a rally from SLP:Sylvania Platinum means it's only £1.56 in the red.

Tragic disappointments today were OPTI:Optibiotix which continues to frustrate. If I didn't already have 10.6% of my holding in this one share I'd buy more while they are so cheap. It's still easily my nemesis share, losing £1,005 but it's also still my favourite share. No share price slippage can detract me from the clear potential in this amazing company. My glasses are as rose tinted as they come - I just hope I don't regret it.

A 3.1% drop in OPTI:Optibiotix cost me a lot today, as did a 4% drop in PAF:Pan African Resources, but by far the biggest impact on the portfolio was KIBO:Kibo Mining dropping 10.1%. I guess I should have expected it, with profit taking after the 25% rise yesterday, but 10% was a bit steep. I still wouldn't risk selling and missing out on the free gold mine shares, and with pay day on the near horizon, there's a very strong desire to top up.

Fortunately the big losses from these three were counteracted by some fantastic rises elsewhere.

CAML:Central Asia Metals is the best run company in my portfolio. They are utterly superb, and the dividend is heading for 7% this year, with interim ex-dividend date just a few weeks away. I've got 6.2% of my holding in this, so a 3.5p rise had a healthy impact.

KIBO:Kibo Mining's rise yesterday propelled it to Star Share status, but it nearly lost that today, dropping to £1,083 profit. CWR:Ceres Power continued the recent gradual climb to £1,070 profit and could regain the Star Share title tomorrow.

The only reason I retain my tiny holding in BLUR:Blur Group is to remind myself of how clueless I was when I started investing. I'm amazed they haven't gone bust yet, but after a 16% rise yesterday, they went up another 9.8% today. Something is going on, as there have been lots of big buys over the last two days on no news, although the big sell-off this afternoon may bring things back to normal. One theory on the ADVFN bulletin board is that people are closing shorts, as you can't do that when a company goes bust. Interesting - and probably more likely than a sudden revival of fortune! I'll leave my massive £109 investment losing 82% and worth only £20 on the off chance something miraculous happens.

Next best riser was TLOU:Tlou Energy, climbing 13.3% after final results posted late in the day, and taking potential profit to £768. These have a hell of a long way to go yet. That rise was nothing compared to the 24.2% increase in RED:RedT Energy, taking them from loss to potential profit of £171. Lots more action to come from this one too.

I'm hoping word will get around about AMYT:Amryt Pharma and IQE:IQE tomorrow so we see their deserved price rise after such good news. I'm also hoping KIBO:Kibo Mining will stay at the current level for a few days to give me the chance to buy more on 15th, although I have vowed to stop putting cash into my portfolio for a few months in order to sort out my Visa bill, so anything I buy will have to be matched by a sell over the next 3 weeks. Although by then the gold mine shares may have been dished out and I could sell some of the Kibo shares - or could I bring myself to do that?

The US markets seem to be getting hammered this evening, which doesn't bode well for UK shares tomorrow. I so badly want to plug that £200 gap and get the combined portfolios into profit. That will take me one step closer to my dream of getting the share/ISA portfolios into profit for the first time since I started this whole escapade, but that's a £1,500 gap to fill. Let's see what tomorrow brings...